Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 729 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Dermata Therapeutics, Inc.
Market Cap
$4.50M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.34M
Net Profit Margin
-3934.91%
TTM Avg
-1854.81%
3Y Avg
-2358.55%
5Y Avg
-1587.79%
Market Cap
$4.58M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.64M
Net Profit Margin
-118.27%
TTM Avg
-13237.88%
3Y Avg
-7961.50%
5Y Avg
-5307.67%
Market Cap
$4.66M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.22M
Net Profit Margin
-285.00%
TTM Avg
-249.81%
3Y Avg
-232.15%
5Y Avg
-165.63%
Market Cap
$4.82M
Net Profit Margin
-3985.58%
TTM Avg
-1467.13%
3Y Avg
-2181.72%
5Y Avg
-1717.85%
Market Cap
$4.11M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | $4.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.34M | -3934.91% | -1854.81% | -2358.55% | -1587.79% |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.64M | -118.27% | -13237.88% | -7961.50% | -5307.67% |
| CalciMedica, Inc. (CALC)vs › | $4.66M | 0.00% | 0.00% | 0.00% | 0.00% |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.22M | -285.00% | -249.81% | -232.15% | -165.63% |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.82M | -3985.58% | -1467.13% | -2181.72% | -1717.85% |
| GRI Bio, Inc. (GRI)vs › | $4.13M | N/A | 0.00% | 0.00% | -421.83% |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.05M | 0.00% | 0.00% | 64.44% | -64.28% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
